Addiction and Harm Reduction

Supervised injection sites, drug decriminalization, involuntary commitment, medication-assisted treatment access, and harm reduction policy.

Overview

Supervised injection sites, drug decriminalization, involuntary commitment, medication-assisted treatment access, and harm reduction policy.

Addiction and Harm Reduction has been the subject of significant news coverage, research, and policy discussion. Key developments include regulatory actions, clinical findings, and public health implications that affect patients, healthcare providers, and policymakers.

  • CDC Reports Sharp Rise in Emergency Room Visits for Cannabis Hyperemesis Syndrome Among Frequent Marijuana Users

  • Phase 2 Clinical Trial Shows THC-CBD Combination Rapidly Reduces Agitation in Advanced Dementia Patients